Flashpoint Therapeutics Announces $50M KAIMRC Partnership
14 Nov 2024 //
PR NEWSWIRE
CancerVax Taps Flashpoint’s Nanotechnology for Universal Cancer Treatment
29 Aug 2024 //
GLOBENEWSWIRE
14 Nov 2024 //
PR NEWSWIRE
29 Aug 2024 //
GLOBENEWSWIRE